home / stock / srra / srra short
Short Information | Sierra Oncology Inc. (NASDAQ:SRRA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 328,509 |
Total Actual Volume | 8,120,374 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 16,425 |
Average Short Percentage | 5.95% |
Is there a SRRA Short Squeeze or Breakout about to happen?
See the SRRA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-30-2022 | $54.98 | $54.99 | $55.17 | $54.98 | 862,822 | 12,524 | 1.45% |
06-29-2022 | $54.95 | $54.97 | $55.09 | $54.94 | 593,169 | 28,774 | 4.85% |
06-28-2022 | $54.96 | $54.96 | $55.09 | $54.95 | 281,515 | 10,703 | 3.8% |
06-27-2022 | $54.95 | $54.95 | $55.05 | $54.93 | 323,948 | 25,651 | 7.92% |
06-24-2022 | $55.1 | $54.91 | $55.19 | $54.65 | 2,379,041 | 35,854 | 1.51% |
06-23-2022 | $54.91 | $54.95 | $54.99 | $54.91 | 184,730 | 6,927 | 3.75% |
06-22-2022 | $54.92 | $54.94 | $54.98 | $54.91 | 250,296 | 23,581 | 9.42% |
06-21-2022 | $54.89 | $54.95 | $54.97 | $54.89 | 366,982 | 4,961 | 1.35% |
06-16-2022 | $54.89 | $54.92 | $54.94 | $54.88 | 208,293 | 15,347 | 7.37% |
06-15-2022 | $54.88 | $54.9 | $54.94 | $54.85 | 232,335 | 7,367 | 3.17% |
06-14-2022 | $54.93 | $54.93 | $54.94 | $54.81 | 181,551 | 20,192 | 11.12% |
06-13-2022 | $54.83 | $54.88 | $54.98 | $54.81 | 131,594 | 9,556 | 7.26% |
06-09-2022 | $54.88 | $54.85 | $54.92 | $54.85 | 152,624 | 18,163 | 11.9% |
06-08-2022 | $54.88 | $54.88 | $54.9 | $54.87 | 129,519 | 8,902 | 6.87% |
06-06-2022 | $54.95 | $54.87 | $55.16 | $54.87 | 244,327 | 16,765 | 6.86% |
06-03-2022 | $54.82 | $54.88 | $54.94 | $54.82 | 174,663 | 9,794 | 5.61% |
06-02-2022 | $54.78 | $54.86 | $54.98 | $54.78 | 474,275 | 10,114 | 2.13% |
06-01-2022 | $54.86 | $54.78 | $55 | $54.66 | 276,073 | 23,945 | 8.67% |
05-31-2022 | $54.79 | $54.78 | $55.17 | $54.585 | 537,858 | 27,422 | 5.1% |
05-26-2022 | $54.67 | $54.73 | $54.78 | $54.67 | 134,759 | 11,967 | 8.88% |
News, Short Squeeze, Breakout and More Instantly...
Dr. Stephen Dilly, Board member and biotechnology veteran, named the next President and CEO John Nicols to retire after ten years leading the transformation and growth of Codexis REDWOOD CITY, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading en...
– Submission seeks approval of momelotinib for the treatment of myelofibrosis – Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submi...